title: Interventional oncology for hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is increasing in incidence. The overall prognosis of patients with liver cancer is poor. The Barcelona Clinic Liver Cancer (BCLC) classification in 5 stages is endorsed by European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Disease (AASLD). This classification is recommended for treatment allocation. Because a small proportion of patients are suitable for curative surgical treatment, various locoregional therapies are widely used to manage patients with HCC. The image-guided therapies, also called interventional radiology or interventional oncology (IO) techniques consisted in percutaneous or endovascular approach. This article reviews the different IO treatments available in HCC patients and the strength of the data.
authors.affiliation: St-Eloi University Hospital, Department of Radiology, 34000 Montpellier, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Delicque
authors.affiliation: Dijon University Hospital, Department of Pharmacy, 21000 Dijon, France.
authors.forename: Mathieu
authors.initials: M
authors.lastname: Boulin
authors.affiliation: St-Eloi University Hospital, Department of Radiology, 34000 Montpellier, France. Electronic address: b-guiu@chu-montpellier.fr.
authors.forename: Boris
authors.initials: B
authors.lastname: Guiu
authors.affiliation: St-Eloi University Hospital, Department of Radiology, 34000 Montpellier, France.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Pelage
authors.affiliation: St-Eloi University Hospital, Department of Radiology, 34000 Montpellier, France.
authors.forename: Laure
authors.initials: L
authors.lastname: Escal
authors.affiliation: St-Eloi University Hospital, Department of Radiology, 34000 Montpellier, France.
authors.forename: Valentina
authors.initials: V
authors.lastname: Schembri
authors.affiliation: St-Eloi University Hospital, Department of Oncology, 34000 Montpellier, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Assenat
authors.affiliation: University and Medical Center of Caen, 14033 Caen cedex, France. Electronic address: fohlen@cyceron.fr.
authors.forename: Audrey
authors.initials: A
authors.lastname: Fohlen
mesh_terms: D055011:Ablation Techniques; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D015642:Radiology, Interventional